RecruitingNCT06787625
Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Pilot Feasibility Study for the Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Sponsor
Regina Elena Cancer Institute
Enrollment
10 participants
Start Date
May 25, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Pilot feasibility study for the development of organoids from primary colorectal tumors and synchronous liver metastases, to prepare organoids from primary colorectal tumors and synchronous liver metastases. The organoids will allow us to study the function of genes targeted by the activity of the NF-Y/p53 complex.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Patients \> 18 years
- Histological and cytological diagnosis of colorectal cancer neoplasia that has developed a liver metastasis
- Patients who are candidates for surgery for colorectal cancer with liver metastasis
- Signing of the relevant informed consent form.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06787625
Related Trials
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
NCT074697091 location
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT071452557 locations
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NCT070850917 locations
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
NCT065633881 location
The AIDPRO-CRC Trial
NCT066450157 locations